Ea8143- A Phase 3 Randomized Study Comparing Perioperative Nivolumab Vs. Observation In Patients With Localized Renal Cell Carcinoma Undergoing Nephrectomy (Prosper Rcc)
Posted Date: Jun 10, 2019
- Investigator: Nilesh Patil
- Specialties: Cancer, Oncology
- Type of Study: Drug
To compare recurrence-free survival (RFS) between patients with renal cell carcinoma randomly assigned to perioperative nivolumab in conjunction with radical or partial nephrectomy with patients randomized to surgery alone
Criteria:
To Be Eligible: Patients Must Be At Least 18 Years Of Age, No Evidence Of Distant Metastases, No Autoimmune Diseases, Uncontrolled Adrenal Insufficiency, Or Hepatitis Disease.
Keywords:
Renal Cancer, Kidney
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com